These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12708500)

  • 1. Anti-cancer effect of genistein in oral squamous cell carcinoma with respect to angiogenesis and in vitro invasion.
    Myoung H; Hong SP; Yun PY; Lee JH; Kim MJ
    Cancer Sci; 2003 Feb; 94(2):215-20. PubMed ID: 12708500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinoma.
    Myoung H; Hong SD; Kim YY; Hong SP; Kim MJ
    Cancer Lett; 2001 Feb; 163(2):191-200. PubMed ID: 11165754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma.
    Riedel F; Götte K; Schwalb J; Bergler W; Hörmann K
    Int J Oncol; 2000 Dec; 17(6):1099-105. PubMed ID: 11078794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semaphorin 4A restricts tumor progression by inhibiting angiogenesis of oral squamous cell carcinoma cells.
    Liu XQ; Yao Y; Mu JW; Yang FY
    Tissue Cell; 2021 Apr; 69():101485. PubMed ID: 33460983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation.
    Ning S; Laird D; Cherrington JM; Knox SJ
    Radiat Res; 2002 Jan; 157(1):45-51. PubMed ID: 11754641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-alpha as well as VEGF, PD-ECGF and bFGF contribute to angiogenesis of esophageal squamous cell carcinoma.
    Li Z; Shimada Y; Uchida S; Maeda M; Kawabe A; Mori A; Itami A; Kano M; Watanabe G; Imamura M
    Int J Oncol; 2000 Sep; 17(3):453-60. PubMed ID: 10938383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma.
    Shinriki S; Jono H; Ota K; Ueda M; Kudo M; Ota T; Oike Y; Endo M; Ibusuki M; Hiraki A; Nakayama H; Yoshitake Y; Shinohara M; Ando Y
    Clin Cancer Res; 2009 Sep; 15(17):5426-34. PubMed ID: 19706815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
    Joseph IB; Isaacs JT
    Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma.
    Sasamura H; Takahashi A; Miyao N; Yanase M; Masumori N; Kitamura H; Itoh N; Tsukamoto T
    Br J Cancer; 2002 Mar; 86(5):768-73. PubMed ID: 11875741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo.
    Hsu SC; Ou CC; Chuang TC; Li JW; Lee YJ; Wang V; Liu JY; Chen CS; Lin SC; Kao MC
    Cancer Lett; 2009 Aug; 281(1):108-16. PubMed ID: 19332363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells.
    Li X; Liu X; Wang J; Wang Z; Jiang W; Reed E; Zhang Y; Liu Y; Li QQ
    Anticancer Res; 2003; 23(3B):2481-7. PubMed ID: 12894531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and clinical significance of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinomas].
    Xu H; Shi XP; Tang WP; Li LX
    Ai Zheng; 2002 Sep; 21(9):983-8. PubMed ID: 12508547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
    Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
    Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer.
    Van Trappen PO; Ryan A; Carroll M; Lecoeur C; Goff L; Gyselman VG; Young BD; Lowe DG; Pepper MS; Shepherd JH; Jacobs IJ
    Br J Cancer; 2002 Aug; 87(5):537-44. PubMed ID: 12189553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.
    von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S
    J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI; Soroceanu L; Strongin AY
    Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eldecalcitol (ED-71), an analog of 1α,25(OH)
    Shintani T; Takatsu F; Rosli SNZ; Usui E; Hamada A; Sumi K; Hayashido Y; Toratani S; Okamoto T
    In Vitro Cell Dev Biol Anim; 2017 Oct; 53(9):810-817. PubMed ID: 28710602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect.
    Nishizaki M; Fujiwara T; Tanida T; Hizuta A; Nishimori H; Tokino T; Nakamura Y; Bouvet M; Roth JA; Tanaka N
    Clin Cancer Res; 1999 May; 5(5):1015-23. PubMed ID: 10353734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
    Shang ZJ; Li JR
    J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.